🇺🇸 FDA
Patent

US 9102626

Multifunctional radical quenchers for the treatment of mitochondrial dysfunction

granted A61PA61P21/02A61P25/14

Quick answer

US patent 9102626 (Multifunctional radical quenchers for the treatment of mitochondrial dysfunction) held by ARIZONA BOARD OF REGENTS, A BODY CORPORATE OF THE STATE OF ARIZONA expires Mon Aug 06 2035 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
ARIZONA BOARD OF REGENTS, A BODY CORPORATE OF THE STATE OF ARIZONA
Grant date
Tue Aug 11 2015 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Aug 06 2035 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
19
CPC classes
A61P, A61P21/02, A61P25/14, A61P25/16, A61P25/28